±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 610  |  »Ø¸´: 11
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

000zgh000

гæ (СÓÐÃûÆø)

[½»Á÷] °ïæ¿´Ò»ÏÂÕ⼸¸ö¾ä×ÓÓÐûÓÐÎÊÌâ

1. Like other malignant diseases, polygenes involvement coupled with accumulation of genetic and epigenetic changes make the high mortality rate without markedly changed.
2.  HCC often coupled with liver dysfunction restrict the use of conventional chemotherapeutics as there are more or less non-selective toxicity with significant systemic side effects.
Çë´óÏÀÃǰﰳ¿´¿´ÕâÁ½¸ö¾ä×ÓÓÐÎÊÌâÂð£¬Èç¹ûÓУ¬ÔõôÐ޸İ¡£¬¼±¼±¼±¡­¡­·Ç³£¸Ðл¹þ¡­¡­£¡£¡£¡

» ²ÂÄãϲ»¶

ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

yuyang031985

½ð³æ (ÕýʽдÊÖ)

¡ï ¡ï
000zgh000(½ð±Ò+1,VIP+0): 9-14 09:03
linghanyuan(½ð±Ò+1,VIP+0):лл½»Á÷ 9-14 14:06
1. Like other malignant diseases, polygenes involvement coupled with the accumulation of genetic and epigenetic changes result in the high mortality rate, which was not changed significantly.
2.  HCC often coupled with liver dysfunction restricts the use of conventional chemotherapeutics, for there is more or less non-selective toxicity of systemic side effects.

¿´¿´°É£¬×öÁ˲¿·Öµ÷Õû
˵˵Äã²»¿ªÐĵÄÊÂÈÃÎÒÃÇ¿ªÐÄһϹþ£¡
2Â¥2009-09-14 08:57:39
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

wangwei2008

ľ³æ (Ö°Òµ×÷¼Ò)

Сľ³æÖ®ÒÆ»¨¹¬Ö÷

Â¥ÉϵÄͦºÃ
3Â¥2009-09-14 09:03:36
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nono2009

³¬¼¶°æÖ÷ (ÎÄѧ̩¶·)

No gains, no pains.

ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐãÇø³¤ÓÅÐã°æÖ÷

¡ï
linghanyuan(½ð±Ò+1,VIP+0):лл½»Á÷ 9-14 20:21
Following the 2nd floor:

1. Like other malignant diseases, polygenes involvement coupled with the accumulation of genetic and epigenetic changes results in the high mortality rate, which was not changed significantly.

(result in => results in?)
4Â¥2009-09-14 20:01:18
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

goodtimega

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

¡ï
linghanyuan(½ð±Ò+1,VIP+0):лл½»Á÷ 9-14 20:22
1. Similar to other malignant diseases, the involvement of  polygenes coupled with the accumulation of genetic and epigenetic changes yields high mortality rate without significant change.
2.  HCC coupled with liver dysfunction restricts the use of conventional chemotherapeutics, for there is more or less non-selective toxicity of systemic side effects.
5Â¥2009-09-14 20:06:37
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

seebrightplan

ľ³æ (ÖøÃûдÊÖ)

Solider

¡ï
linghanyuan(½ð±Ò+1,VIP+0):¹ÄÀø½»Á÷ 9-25 15:28
1. Like other malignant diseases, the involvement of the polygenes involvement coupled with the accumulation of genetic and epigenetic changes results in high mortality rate with neglected changing.
2.  HCC often coupled with liver dysfunction restricts the use of the conventional chemotherapeutics since there ismore or less non-selective toxicity with significant systemic side effects.
Ö»´ËÒ»ÉúĪÌý´©ÁÖ´òÒ¶Éù£¬ºÎ·ÁÒ÷Ð¥ÇÒÐìÐС£ÖñÕÈâЬÇáʤÂí£¬Ë­Å£¿Ò»ËòÑÌÓêÈÎÆ½Éú¡£ÁÏÇÍ´º·ç´µ¾ÆÐÑ£¬Î¢À䣬ɽͷбÕÕÈ´ÏàÓ­¡£»ØÊ×ÏòÀ´Ïôɪ´¦£¬¹éÈ¥£¬Ò²ÎÞ·çÓêÒ².
6Â¥2009-09-15 12:52:23
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

abstqq123

гæ (СÓÐÃûÆø)

¡ï
linghanyuan(½ð±Ò+1,VIP+0):¹ÄÀøÐ³æ 9-25 15:27
Following the 2nd floor:

1. Like other malignant diseases, polygenes involvement coupled with the accumulation of genetic and epigenetic changes results in the high mortality rate, which was not changed significantly.

(result in => results in?)
7Â¥2009-09-18 13:56:49
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

jw227

ľ³æ (ÖøÃûдÊÖ)

¿ÎÌâ×鳤

¡ï
linghanyuan(½ð±Ò+1,VIP+0):лл½»Á÷ 9-25 15:27
Like other malignant diseases, polygenes involvement coupled with  genetic and epigenetic accumulation changes led to the  high mortality rate unchanged

HCC together with liver dysfunction restricts the use of conventional chemotherapeutics since there are more or less non-selective toxicity in significant systemic side effects.
ÎÒÊÇÀ´ÏûDzµÄ
8Â¥2009-09-20 13:36:15
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

chaokai

½ð³æ (³õÈëÎÄ̳)

¡ï
linghanyuan(½ð±Ò+1,VIP+0):¹ÄÀøÐ³æ 9-25 15:28
moralityÒѾ­±íʾËÀÍöÂÊ ËùÒÔӦȥµôrate
9Â¥2009-09-24 12:09:30
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

·É×ßµÄÏ£Íû

ľ³æ (ÖøÃûдÊÖ)

ЦµÄÌ«³Õµß

дµÃ²»´í£¬Ð»Ð»Ö¸µ¼
10Â¥2009-10-03 14:12:33
ÒÑÔÄ   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ 000zgh000 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 288Çóµ÷¼Á£¬Ò»Ö¾Ô¸»ªÄÏÀí¹¤´óѧ071005 +4 ioodiiij 2026-04-04 4/200 2026-04-04 22:49 by barlinike
[¿¼ÑÐ] Ò»Ö¾Ô¸µç×ӿƼ¼´óѧ085600²ÄÁÏÓ뻯¹¤ 329·ÖÇóµ÷¼Á +5 Naiko 2026-04-04 5/250 2026-04-04 22:05 by lbsjt
[¿¼ÑÐ] 085404×Ü·Ö289£¬Çóµ÷¼Á +4 Acesczlo 2026-03-29 4/200 2026-04-04 21:43 by hemengdong
[¿¼ÑÐ] 292Çóµ÷¼Á +11 2022080213 2026-04-04 13/650 2026-04-04 18:38 by macy2011
[¿¼ÑÐ] 085701Çóµ÷¼Á +7 ¹¨ÓíÃú 2026-04-04 8/400 2026-04-04 13:49 by ССÊ÷2024
[¿¼ÑÐ] Ò»Ö¾Ô¸C9µÄ»¯Ñ§¹¤³Ì£¨085602£© 340·Ö£¬¸Ð¾õУÄÚµ÷¼ÁÎÞÍû£¬Çóµ÷¼Á +9 ÍòÊÂÒËÕé 2026-04-04 9/450 2026-04-04 11:49 by à£à£à£0119
[¿¼ÑÐ] Ò»Ö¾Ô¸½­ÄÏ´óѧ085501»úе¹¤³Ìר˶326·Ö£¬±¾¿Æ¼Ñľ˹´óѧ +4 ¹ËÈô¸¡Éú 2026-04-03 8/400 2026-04-03 22:31 by zhq0425
[¿¼ÑÐ] »¯¹¤Çóµ÷¼Á +11 ÀóÏã֥ʿҬÄÌ 2026-04-03 11/550 2026-04-03 22:06 by à£à£à£0119
[¿¼ÑÐ] »¯¹¤µ÷¼Á303·Ö£¬¹ýËļ¶ +28 ÆÜÎà´ý·ç 2026-04-02 28/1400 2026-04-03 21:40 by qlm5820
[¿¼ÑÐ] 266Çóµ÷¼Á +18 ÑôÑôÍÛÈû 2026-04-01 18/900 2026-04-03 18:38 by zllcz
[¿¼ÑÐ] ²ÄÁÏ¿ÆÑ§Ó빤³Ì339Çóµ÷¼Á +12 hyz0119 2026-03-31 13/650 2026-04-03 18:33 by lsÁõ˧
[¿¼ÑÐ] 0856£¬269·ÖÇóµ÷¼Á +15 ÓÐѧÉϾÍÐÐÇóÇóÁ 2026-03-30 18/900 2026-04-03 16:50 by melodiousnow
[¿¼ÑÐ] 330Çóµ÷¼Á +3 °×ÉñÎØºôºô 2026-04-02 3/150 2026-04-03 10:15 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ר˶ 351 086100 Ò²ÊÇ¿¼µÄ²Ä¿Æ»ù ±¾¿ÆÒ²ÊDzÄÁÏ +8 202451007219 2026-04-02 8/400 2026-04-03 09:50 by À¶ÔÆË¼Óê
[¿¼ÑÐ] ÖØÇì´óѧ²ÄÁÏÓ뻯¹¤085600£¬³õÊÔ370+£¬ÇóÇóµ÷¼Á½¨Òé +8 shzhou_ 2026-04-01 9/450 2026-04-03 09:31 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 260Çóµ÷¼Á +6 ÖìÜÆÁÕ 2026-04-02 6/300 2026-04-02 20:27 by 6781022
[¿¼ÑÐ] 285Çóµ÷¼Á +8 AZMK 2026-04-02 11/550 2026-04-02 20:16 by yulian1987
[¿¼ÑÐ] 348Çóµ÷¼Á +6 ÎâÑå׿24k 2026-04-02 6/300 2026-04-02 14:07 by ¸øÄãÄã×¢ÒâÐÝÏ¢
[¿¼ÑÐ] µ÷¼Á +3 ºÃºÃ¶ÁÊé¡£ 2026-04-01 3/150 2026-04-01 17:06 by zhouyuwinner
[¿¼ÑÐ] Çóµ÷¼Á +7 Çà´º²ÃΪÈý½Ø 2026-03-29 7/350 2026-03-30 13:14 by laoshidan
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û